Physician profile
Tara Robinson
NPI 1689677890
$6,501.46
in general payments reported to CMS, 2019-2025
44 companies · $18.27 in 2025
The $18.27 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,106 · 2020: $1,519 · 2021: $1,299 · 2022: $1,377 · 2023: $1,056 · 2024: $127 · 2025: $18.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175 · Education: $25.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.76 |
| Education | $25.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,028.22 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $619.33 | 2019-2024 | Vraylar, Linzess, Viberzi |
| Pfizer INC. | $612.70 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $499.46 | 2019-2023 | Spiriva Respimat, Jardiance |
| Astrazeneca Pharmaceuticals LP | $350.03 | 2019-2024 | Breztri, Airsupra, Farxiga |
| Sanofi-Aventis U.S. LLC | $303.02 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $240.27 | 2019-2022 | |
| Exact Sciences Corporation | $233.81 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $208.89 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $208.69 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $168.86 | 2019-2023 | Trintellix |
| Amarin Pharma, INC. | $165.06 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $156.88 | 2019-2022 | |
| Allergan, INC. | $128.21 | 2019-2020 | |
| Astellas Pharma US INC | $125.63 | 2019-2023 | Veozah |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.